Horsham, Pennsylvania, March 15, 2024–(BUSINESS WIRE)–Myonex, a leading global clinical trial supply company, will acquire Creapharm's clinical packaging and distribution and commercial packaging businesses and bioservices, headquartered in Reims, France. We have reached an agreement with the owner of Creapharm Group. Located in Bordeaux and Bailly-Romainvilliers, France, and Marietta, Georgia, USA.
Completion of this transaction is subject to regulatory approval.
This strategic acquisition brings complementary strengths to the market. Myonex is a market leader in pharmaceutical procurement and clinical trial formulation services, with expanding franchises in clinical packaging, labeling and distribution, ancillary equipment and supplies. Creapharm brings scale and deep expertise in clinical packaging and distribution alongside its existing franchise in commercial packaging and supply chain management for advanced therapeutic medicinal products (ATMPs).
“By combining, we can fill a gap in the market with breadth and depth of expertise, integrated services and exceptional customer focus,” said James Lovett, CEO of Minex. “Myonex looks forward to working with our colleagues at Creapharm to be agile and responsive to our customers' needs.”
“Growing with Myonex is a clear step forward for Creapharm, contributing our expertise and wide range of packaging solutions to Creapharm’s business, and making clinical practice more effective, efficient and patient-centric at all times. We are expanding the range of services we offer to support testing,'' said Eric Placet, CEO and Founder of Creapharm. “Creapharm is pleased to evolve His Myonex’s overall mission by complementing our strengths and providing the scale and flexibility to meet our clients’ needs.”
“We have complementary strengths and cultural alignments that make this an exciting solution for the industry, our colleagues, and our clients,” said Michael Cohen, co-owner and executive chairman of Myonex. . “We share a tradition of entrepreneurship and engagement with our team members, and a commitment to social and environmental responsibility to ensure success for our clients, clinical trial sites, and patients. ”
Subject to successful completion of the transaction, Mike Cohen will continue to serve as Chairman of the combined company and James Lovett will serve as CEO. In addition to reinvesting in Myonex, Eric Plassett plans to join Myonex's board of directors and further strengthen the relationship. Creapharm's girlfriend Carla Da Costa will join the combined management team, and Edouard Placet will also take on a strategic and leadership role in the combined company.
About Minex
Myonex is a leading global clinical trial supply company, providing customized solutions in pharmaceutical procurement, packaging and labeling, equipment and consumables, and market-leading CTRx solutions to suit the specific requirements and complexity of each trial. We offer With offices in the US, EU, and UK, we partner with pharmaceutical companies, biotech companies, contract research organizations (CROs), and other clinical trial service providers seeking flexible and comprehensive solutions for their clinical trial supply needs. Masu. For more information, please visit www.mionex.com.
About Cree Farm
Creapharm leverages decades of experience in global clinical trial supply management to support leading pharmaceutical and biotech companies with customized solutions. Creapharm has strong expertise in cold chain management and has recently developed ultra-cold solutions to handle biologics and ATMP supply chain management. For over-the-counter health products, Creapharm provides specialized commercial packaging services to the pharmaceutical and food supplement industries. For more information, please visit www.creapharm-pharma.com.
View source version on businesswire.com. https://www.businesswire.com/news/home/20240315996717/ja/
contact address
Marianne Walsh
+1 267-307-0876
